AAAAAA

   
Results: 1-10 |
Results: 10
Investigation of primary human immunodeficiency virus infection in patients who test positive for heterophile antibody
Authors: Walensky, RP Rosenberg, ES Ferraro, MJ Losina, E Walker, BD Freedberg, KA
Citation: Rp. Walensky et al., Investigation of primary human immunodeficiency virus infection in patients who test positive for heterophile antibody, CLIN INF D, 33(4), 2001, pp. 570-572
Should we reevaluate antibiotic breakpoints?
Authors: Ferraro, MJ
Citation: Mj. Ferraro, Should we reevaluate antibiotic breakpoints?, CLIN INF D, 33, 2001, pp. S227-S229
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Authors: Tsiodras, S Gold, HS Sakoulas, G Eliopoulos, GM Wennersten, C Venkataraman, L Moellering, RC Ferraro, MJ
Citation: S. Tsiodras et al., Linezolid resistance in a clinical isolate of Staphylococcus aureus, LANCET, 358(9277), 2001, pp. 207-208
Optimal inoculation methods and quality control for the NCCLS oxacillin agar screen test for detection of oxacillin resistance in Staphylococcus aureus
Authors: Swenson, JM Spargo, J Tenover, FC Ferraro, MJ
Citation: Jm. Swenson et al., Optimal inoculation methods and quality control for the NCCLS oxacillin agar screen test for detection of oxacillin resistance in Staphylococcus aureus, J CLIN MICR, 39(10), 2001, pp. 3781-3784
Levofloxacin-resistant Streptococcus pneumoniae: Second look - Reply
Authors: Jorgensen, JH Weigel, LM Swenson, JM Whitney, CG Tenover, FC Ferraro, MJ
Citation: Jh. Jorgensen et al., Levofloxacin-resistant Streptococcus pneumoniae: Second look - Reply, ANTIM AG CH, 45(7), 2001, pp. 2183-2184
Molecular resistance testing of Helicobacter pylori in gastric biopsies
Authors: Pena, JA Fox, JG Ferraro, MJ Versalovic, J
Citation: Ja. Pena et al., Molecular resistance testing of Helicobacter pylori in gastric biopsies, ARCH PATH L, 125(4), 2001, pp. 493-497
Antimicrobial susceptibility testing: Special needs for fastidious organisms and difficult-to-detect resistance mechanisms
Authors: Jorgensen, JH Ferraro, MJ
Citation: Jh. Jorgensen et Mj. Ferraro, Antimicrobial susceptibility testing: Special needs for fastidious organisms and difficult-to-detect resistance mechanisms, CLIN INF D, 30(5), 2000, pp. 799-808
Characterization of the extended-spectrum beta-lactamase reference strain,Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18
Authors: Rasheed, JK Anderson, GJ Yigit, H Queenan, AM Domenech-Sanchez, A Swenson, JM Biddle, JW Ferraro, MJ Jacoby, GA Tenover, FC
Citation: Jk. Rasheed et al., Characterization of the extended-spectrum beta-lactamase reference strain,Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18, ANTIM AG CH, 44(9), 2000, pp. 2382-2388
Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacinagainst recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae
Authors: Jorgensen, JH Weigel, LM Swenson, JM Whitney, CG Ferraro, MJ Tenover, FC
Citation: Jh. Jorgensen et al., Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacinagainst recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae, ANTIM AG CH, 44(11), 2000, pp. 2962-2968
Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci
Authors: Jorgensen, JH Weigel, LM Ferraro, MJ Swenson, JM Tenover, FC
Citation: Jh. Jorgensen et al., Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci, ANTIM AG CH, 43(2), 1999, pp. 329-334
Risultati: 1-10 |